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ABSTRACT
Objectives: This proposed work describes simple and extraction free visible methods for the estimation of darunavir ethanolate (DNV) in bulk and 
tablet formulations. The methodology involves diazotization of DNV with nitrous acid followed by coupling with chromotropic acid (CA) (Method A)/
Bratton Marshall Reagent (Method B)/α-naphthol (Method C) to form colored products.
Methods: All the methods were developed using a PerkinElmer (LAMBDA 25) UV–Visible spectrophotometer interfaced with UV Win lab software 
and 1 cm quartz cells.
Results: Spectrophotometrically, DNV is estimated at 520 nm, 544 nm, and 464 nm for the reddish-pink color produced by CA, dark violet color 
with NED, and dark-greenish yellow with α-naphthol, respectively. The linear relationship was observed between absorbance and the corresponding 
concentration of drug in the range of 100–350 µg/mL, 10–100 µg/mL, and 10–60 µg/mL for Methods A, B, and C, respectively.
Conclusion: The colorimetric methods were extensively validated as per the ICH guidelines. The developed methods were proven to be more accurate 
and precise by the statistical analysis.
Keywords: Darunavir, Chromotropic acid, Bratton Marshall reagent, α-Naphthol.
INTRODUCTION
Darunavir (DNV) ethanolate is chemically [1S, 2R] -3-[[(4 amino 
phenyl) sulfonyl](2-methyl propyl) amino]-2-hydroxy-1-(phenyl 
methyl)propyl]-carbamic acid (3R,3aS,6aR) hexa hydro furo [2,3-b]
furan-3-yl ester mono ethanolate (Fig. 1) used as an oral retroviral 
agent and an inhibitor of human immunodeficiency virus protease [1]. 
It prevents HIV replication by binding to the enzyme’s active site, 
thereby preventing the dimerization and the catalytic activity of the 
HIV-1 protease. It selectively inhibits the cleavage of HIV-encoded Gag-
Pol polyproteins in virus-infected cells, which prevents the formation 
of mature infectious virus particles and coadministered with ritonavir.
Few reversed-phase high-performance liquid chromatography 
methods [1-6], UV/visible methods [7-10], and high-performance thin-
layer chromatography (HPTLC) methods [11] were found through the 
extensive literature search on the quantization of DNV in pure and dosage 
forms. The existing HPLC and HPTLC methods are laborious, time-
consuming and need sample pretreatment. By virtue, spectrophotometry 
is the instrumental technique of choice eventually by its simplicity, 
sensitivity, and low cost for the underdeveloped and developing nations. 
The existing visible methods were based on oxidation or substitution 
reactions. Spectrophotometric methods based on diazotization and 
coupling method were not reported earlier. Based on the need for more 
simple analytical methods, the present work describes three simple, time-
effective, and sensitive methods based on the diazotization and coupling 
process for the quantization of DNV in pure and tablet dosage forms.
METHODS
Equipment
Double-beam PerkinElmer (LAMBDA 25) UV-vis spectrophotometer 
interfaced with UV WIN lab software and 1 cm quartz cuvettes were 
used for spectral measurements. Sartorius balance was used for 
weighing the samples.
Chemicals
DNV was obtained as a gift sample from Aurobindo Pharma Ltd., 
Hyderabad. Ethanol, chromotropic acid (CA), Bratton–Marshall Reagent 
(BMR), α-naphthol, ammonium sulfamate, hydrochloric acid, and 
sodium nitrite were used for the experimental work. All the chemicals 
used in the experimental work were of AR Grade.
Preparation of stock solution of DNV
25 mg of DNV was accurately weighed and transferred to a 25 mL 
volumetric flask and dissolved and diluted to final volume with ethanol. 
The resulting solution has a concentration of 1 mg/mL.
Preparation of reagents
0.2%W/V BMR
200 mg of BMR was weighed and dissolved to make 100 mL with water.
0.5% W/V sodium nitrite
500 mg of sodium nitrite was weighed and dissolved to make 100 mL 
with water.
0.5% W/V ammonium sulfamate
500 mg of ammonium sulfamate was weighed and dissolved to make 
100 mL with water.
0.2% W/V CA
200 mg of CA was weighed and dissolved in a mixture of 75 mL of 
concentrated sulfuric acid and 33 mL of distilled water.
0.2% W/V α-naphthol
200 mg of α-naphthol was weighed and dissolved to make 100 mL with 
ethanol.
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5N HCl
42.5 mL of concentrated hydrochloric acid was taken into a 100 mL of 
volumetric flask and dissolved in distilled water, and the final volume 
was made up to 100 mL with distilled water.
Procedure for calibration standards (Method A)
In a series of 10 mL volumetric flasks, 1–4 mL of working standard 
solution of DNV was pipette out, 0.2 mL of hydrochloric acid, 0.2 mL 
of sodium nitrite, 0.2 mL of ammonium sulfamate, and 0.7 mL of CA 
were added and then kept aside for 15 min, and then, the final volume 
was made up to 10 mL with water. The absorbance of the reddish–
pink colored chromogen was measured at 520 nm against the reagent 
blank.
Procedure for calibration standards (Method B)
In a series of 10 mL volumetric flasks, 0.1–1 mL of working standard 
solution of DNV was pipette out, 0.6 mL of hydrochloric acid, 0.5 mL of 
sodium nitrite, 0.6 mL of ammonium sulfamate, and 0.6 mL of BMR were 
added, and then, the final volume was made up to 10 mL with ethanol. 
The absorbance of the dark violet-colored product was measured at 
544 nm against the reagent blank.
Procedure for calibration standards (Method C)
In a series of 10 mL volumetric flasks, 0.1–0.6 mL of working standard 
solution of DNV was pipetted out, 0.8 mL of hydrochloric acid, 0.4 mL 
of sodium nitrite, 0.8 mL of ammonium sulfamate, and 0.8 mL of 
α-naphthol were added, and then, the final volume was made up to 10 
mL with ethanol. The absorbance of the dark greenish-yellow-colored 
product was measured at 464 nm against the reagent blank.
Assay procedure for Methods A-C
20 tablets of commercial samples of DNV were accurately weighed 
and powdered. Tablet powder equivalent to 25 mg was weighed, then 
dissolved and diluted to 25 mL using ethanol, and filtered. Then, the 
solution was subjected to the respective procedure described above 
and the absorbance was noted.
RESULTS AND DISCUSSION
Optimization of the method
The spectral characteristics of all the methods using CA, BMR, and 
α-naphthol reagents were studied as per standard optimization 
parameters [12,13].
Method optimization
Order of addition and reagent concentration
The order of addition of reagents, optimum concentration, and volume 
was studied on the basis of their ability to give a maximum absorbance. 
To find out whether the order of addition and reagent concentration 
has any influence on absorbance intensity, suitable concentration of 
the reagent and order of addition of reagents were studied by varying 
one parameter at a time keeping the other constant. The results are 
presented in Table 1.
Effect of temperature and stability of colored products
Effect of temperature on reaction conditions was studied; if the 
temperature is maintained above 40°C, the intensity of absorbance 
reduces; lowering the temperature has no effect on absorbance. Hence, 
these methods were carried out at room temperature. The formation 
of the colored complex was complete in 15 min time intervals at room 
temperature for Method A. For Methods B and C, the color formation 
was complete within 4–5 min. The stability of colored product was 
studied by taking the absorbance at various time intervals, and the 
color of the reaction products was emphasised to be stable for 2 h.
Method validation
All the methods were validated as per the ICH guidelines [I4] for accuracy, 
precision, linearity, limit of detection (LOD), limit of quantification 
(LOQ), ruggedness, and robustness, and the results were found to be 
satisfactory. Regression parameters are presented in Table 2.
Linearity and range
At the described experimental conditions, the standard calibration 
curves were constructed by plotting an increase in absorbance with 
concentration.
The linear correlation found between absorbance and concentration 
of DNV is presented in Table 2. The statistical parameters given in the 
regression equation were calculated from the calibration graphs. The 
high values of the regression coefficients and low values of y-intercepts 
of the regression equations proved the linearity of the calibration 
curves.
LOD and LOQ
LOD and LOQ were determined by analyzing progressively lower 
concentrations of standard solution using optimized conditions, and 
the results are presented in Table 2.
Precision
The precision of the proposed methods was assessed by determining 
the relative standard deviation (RSD) of six replicate analyses on the 
Fig. 1: Chemical structure of Darunavir
Table 1: A study of the order of addition and reagent 
concentration
Method Order of addition and reagent concentration
Method A DNV+HCl (0.2 mL) + SN (0.2 mL) + AS (0.2 mL) 
+ C.A (0.7 mL)
Method B DNV+HCl (0.6 mL) +SN (0.5 mL) + AS (0.6 mL) 
 + NED (0.6 mL)
Method C DNV+HCl (0.8 mL) +SN (0.4 mL) + AS (0.8 mL) 
 + α-N (0.8 mL)
Table 2: Optical and regression parameters for Methods A, B, 
and C
Parameters Method A Method B Method C
λmax, nm 520 544 464




Sandell’s sensitivity  
(µg/cm2)/0.001 abs unit
10×10−3 6.0×10−3 3.0×10−2
LOD, µg/mL 4.8044 1.4095 0.8583
LOQ, µg/mL 16.0146 4.6984 2.8611
Slope (m) 0.008717 0.02119 0.03255
Intercept (b) −0.003320 0.01716 0.005964
Correlation coefficient (r) 0.9999 0.9999 0.9999
LOD: Limit of detection, LOQ: Limit of quantification
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same solution containing a fixed concentration of DNV (within Beer’s 
law limit). The low % RSD of the intra- and inter-day repeatability 
studies corroborates precision of the method. Table 3 represents the 
results of precision studies.
Robustness and ruggedness
Robustness was ascertained by the low %RSD by narrow alteration 
of the optimized parameters. System-to-system/analyst-to-analyst 
variability study was conducted for ruggedness studies. The %RSD was 
found to be <1 by both studies, which corroborates that the method is 
rugged and robust.
Accuracy
The validity and accuracy of the proposed methods were further 
assessed by recovery studies using the standard addition technique. 
For this purpose, a known quantity of pure drug at three different 
levels was spiked to the fixed and known quantity of pre-analyzed 
formulation samples, and the concentration of the drug was estimated 
by the proposed methods. The results given in Table 4 establish that the 
methods were reproducible by low SD and %RSD. No interference was 
evidenced from the common formulation excipient.
Application of the proposed method to the formulation
To evaluate the proposed methods, they were applied to the 
determination of DNV in commercial formulations. The recoveries 
are close to 100%, indicating that there is no serious interference in 
samples. The good agreement between these results and known values 
indicates the successful application of the proposed methods for the 
determination of DNV in formulations. The results are given in Table 5.
DISCUSSION
The proposed visible methods were successfully developed for 
the estimation of DNV. The methods were specific and selective 
by diazotization and coupling. The spectral analysis of DNV shows 
maximum absorbance at 520 nm, 544 nm, and 464 nm by Methods 
A-C, with linearity range between 100 and 350 µg/mL, 10 and 100, 
and 10 and 60 by Methods A-C, respectively. The very low LOD and 
LOQ obtained by the proposed methods proven the methods to be 
sensitive. The methods were validated in terms of accuracy, precision, 
and robustness as per the ICH guidelines. The low percentage relative 
SD value proves high precision of the method with absolute robustness. 
The regression analysis depicted in Table 2 shows a correlation 
coefficient nearer to 1. The results of the accuracy studies were nearer 
to 100%. These methods will reduce the tedious procedures involved 
in the preparation of sample and solvent system as like HPLC. The 
application of the proposed methods to the tablet formulation revealed 
that no excipients of tablet formulation interfere with the analysis of 
DNV by all proposed methods.
CONCLUSION
The new, cost-effective, simple, and sensitive visible methods using CA, 
NED, and α-naphthol were developed for the determination of DNV 
in bulk and pharmaceutical formulations. The developed methods 
were also validated. From the statistical data, it was found that the 
proposed methods were accurate, precise, and reproducible and can be 
successfully applied to the analysis of the same and could make a better 
alternative to the existing methods.
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